ABVAX | VIVAX | ABVAX / VIVAX | |
Total Expense Ratio | 0.89 | 0.17 | 524% |
Annual Report Gross Expense Ratio | 0.89 | 0.17 | 524% |
Fund Existence | 25 years | 33 years | - |
Gain YTD | 11.275 | 9.193 | 123% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 439M | 208B | 0% |
Annual Yield % from dividends | 0.90 | 1.97 | 46% |
Returns for 1 year | -2.35 | 4.11 | -57% |
Returns for 3 years | 24.67 | 42.28 | 58% |
Returns for 5 years | 44.26 | 70.92 | 62% |
Returns for 10 years | 49.28 | 128.31 | 38% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SMN | 14.19 | 0.13 | +0.89% |
ProShares UltraShort Materials | |||
UMAY | 35.88 | 0.09 | +0.26% |
Innovator U.S. Equity Ultra BffrETF™-May | |||
DFEV | 32.41 | 0.03 | +0.09% |
Dimensional Emerging Markets Value ETF | |||
BNY | 10.33 | -0.02 | -0.19% |
BlackRock New York Municipal Income Trust | |||
OOQB | 16.11 | -0.14 | -0.86% |
One+One Nasdaq-100 and Bitcoin ETF |